Showing results (191-200 of 200) with videos related to
Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Journal for Immunotherapy of Cancer|May 28, 2026
Pretreatment intratumoral mature TLSs in non-clear cell renal cell carcinoma are associated with response to immunotherapy rechallengeYanfeng Tang, Junru Chen, Jue Hu, et al.Journal of Cancer Research and Clinical Oncology|March 13, 2023
Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancerNanwei Xu, Jinge Zhao, Fengnian Zhao, et al.Frontiers in Microbiology|October 28, 2021
Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut MicrobiotaSijia Li, Siyuan Yang, Yuzheng Zhou, et al.Genome Medicine|May 2, 2023
Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase-deficient renal cell carcinomaJiayu Liang, Guangxi Sun, Xiuyi Pan, et al.Cancer Research|October 17, 2023
Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the ProstateJinge Zhao, Nanwei Xu, Sha Zhu, et al.Nature Communications|September 7, 2021
Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinomaGuangxi Sun, Junru Chen, Jiayu Liang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
Integrated Molecular Characterization of Fumarate Hydratase-deficient Renal Cell CarcinomaGuangxi Sun, Xingming Zhang, Jiayu Liang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2024
Memory/Active T-Cell Activation Is Associated with Immunotherapeutic Response in Fumarate Hydratase-Deficient Renal Cell CarcinomaJunru Chen, Xu Hu, Junjie Zhao, et al.Nature Communications|May 12, 2025
Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targetsXingming Zhang, Junjie Zhao, Xiaoxue Yin, et al.JAMA Oncology|August 14, 2025
Sintilimab Plus Axitinib for Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical TrialXingming Zhang, Haoyang Liu, Jiayu Liang, et al.Pageof 20